September 17, 2003

FOR: ZOLL Medical Corporation

INVESTOR CONTACT: A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
(978) 421-9655
PRESS CONTACT: Robert Minicucci
Corporate Communications Manager
ZOLL Medical Corporation
+1 (978) 421-9832
rminicucci@zoll.com



FOR IMMEDIATE RELEASE

ZOLL MEDICAL CORPORATION TO SPEAK AT UBS GLOBAL LIFE SCIENCES CONFERENCE

Wednesday, September 17, 2003 – Chelmsford, MA, – ZOLL Medical Corporation (Nasdaq: ZOLL), a manufacturer of non-invasive cardiac resuscitation devices which provide pacing and defibrillation, today announced that Richard A. Packer, its Chief Executive Officer, will speak at 4:00 p.m. on Tuesday, September 23, 2003 in New York at the UBS Global Life Sciences Conference. Mr. Packer will discuss ZOLL’s business highlights and its financial results and outlook. In addition, he may answer one or more questions concerning business and financial developments, matters and trends, some of the responses to which may contain information that has not been previously disclosed.

A live webcast of ZOLL’s presentation will be accessible through the UBS website at http://www.ibb.ubs.com/Conferences/co_highlights.shtml

ZOLL Medical Corporation, headquartered in Chelmsford, MA, designs, manufactures and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. Used by health care professionals to provide both types of cardiac resuscitation – pacing and defibrillation – these products are essential in the emergency treatment of cardiac arrest victims, both inside and outside the hospital. ZOLL also designs and markets software that automates collection and management of both clinical and non-clinical data for emergency medical service providers. ZOLL has operations in the United States, Canada, United Kingdom, Germany, France, the Netherlands, and Australia, and business partners in all of the world’s major markets. For more information about ZOLL and its products, visit the ZOLL web site at www.zoll.com.

##